FDA approves new type of non-opioid pain medication in two decades
The FDA has approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
FDA approves painkiller designed to eliminate risk of addiction
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S. Food ...
Boston Herald21d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
(Vertex Pharmaceuticals via AP) Opioids reduce pain by binding to receptors in the brain that receive nerve signals from different parts of the body. Those chemical interactions also give rise to ...
The New York Times22d
F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...
Vertex Pharma Just Scored a Major FDA Approval. Is the Stock a No-Brainer Buy Now?
Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...
The Boston Globe19d
At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
blocking pain signals from reaching the brain to begin with. As a result, Vertex executives say, it cannot cause addiction and is worth considerably more than an opioid, especially considering the ...
The Motley Fool18d
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Journavx is a non-opioid drug that prevents peripheral nerves from sending pain signals to the brain. Journavx is one of three recently approved drugs in Vertex Pharmaceuticals' product lineup.